The home contest comes as Elon looks to extend a three-game winning streak that has landed the Phoenix at No. 23 in national rankings.
Riding a three-game winning streak that includes a pair of decisions over ranked opponents, the Elon University football team comes back to Rhodes Stadium for a Top-25 matchup with the Albany Great Danes.
Elon, which is ranked No. 23 this week, and the Great Danes, ranked No. 19, will square off in a 2 p.m. contest on the Elon campus on Saturday, Sept. 30.
Fans who can’t make it to Rhodes Stadium on Saturday can watch the game live as part of CAA Football’s Game of the Week package through College Sports Live. Scott Sudikoff and Brandon Noble will have the call on that broadcast. Phoenix faithful can also listen to the game on WSML 104.5 FM and 1200 AM as well as at elonphoenix.com as and Matt Krause will call the action. The pregame radio coverage will begin at 1 p.m.
Coming to the game? Join the cheerleaders and band as they welcome the Phoenix to Rhodes Stadium during the Phoenix Walk down Bank of America Drive. This week’s walk will occur at 11:30 a.m.
For more information on ticketing, parking and directions to Rhodes Stadium, please visit the Football Game Day web page. For the second straight year, Elon will offer a digital game program that includes rosters, stats and video features. Make sure you are prepared for the game by utilizing the digital program.
COACH TO CURE MD
In a partnership with the American Football Coaches Association (AFCA), the Elon football team will participate in Coach to Cure MD, the national game day charity project of the AFCA. Now celebrating its 10th anniversary, Coach to Cure MD seeks to raise awareness and money to fund research for Duchenne muscular dystrophy, the most prolific lethal genetic disorder of childhood. During the games of Sept. 30, thousands of AFCA members will be wearing Coach to Cure MD shoulder patches to help raise awareness of the program. Over the last nine years, Coach to Cure MD has raised over $1.5 million. Every dollar raised has helped advance promising research, which led to two drug approvals for Duchenne in the last year alone.